Heidi Helgeson
Family Medicine · del Norte, CONPI 1740474931
Payments from drug & device makers
Across 80 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$560
- AstraZeneca$172
- Mylan Specialty L.p.$51
- Medtronic$50
- Pfizer$50
- Sanofi-aventis U.S. LLC$47
- plus $417 from 17 others
What the payments were for
- Food & beverage$1,347100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 33 | $560 |
| AstraZeneca | 10 | $172 |
| Mylan Specialty L.p. | 4 | $51 |
| Medtronic(2 entities) | 3 | $50 |
| Pfizer | 3 | $50 |
| Sanofi-aventis U.S. LLC | 3 | $47 |
| Agile Therapeutics, Inc. | 2 | $43 |
| Pacira Therapeutics, Inc. | 2 | $34 |
| Novo Nordisk | 2 | $34 |
| Gilead | 2 | $33 |
| Astellas Pharma US Inc | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Sunovion Pharmaceuticals Inc. | 2 | $28 |
| Xeris Pharmaceuticals, Inc. | 2 | $27 |
| Medicomp Inc | 1 | $23 |
| Harmony Biosciences LLC | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| Eisai Inc. | 1 | $18 |
| Optos, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Braeburn Inc. | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Bioventus LLC | 1 | $13 |
How this compares
$1,347 in reported general payments places this provider in the 80th percentile of 2,079 family medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 149 | $107,416 |
| TrulicityDulaglutide | 88 | $93,418 |
| XareltoRivaroxaban | 125 | $73,872 |
| OzempicSemaglutide | 34 | $49,135 |
| JanuviaSitagliptin Phosphate | 73 | $47,422 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 42 | $45,155 |
| JardianceEmpagliflozin | 60 | $37,772 |
| RybelsusSemaglutide | 16 | $32,706 |
| MyrbetriqMirabegron | 72 | $23,489 |
| Spiriva RespimatTiotropium Bromide | 35 | $23,300 |
| OxycontinOxycodone Hcl | 28 | $21,439 |
| Tresiba Flextouch U-100Insulin Degludec | 22 | $20,276 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 20 | $18,629 |
| Victoza 2-PakLiraglutide | 18 | $15,896 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 131 | $14,532 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Abrysvo | $50 | $111,772162 claims |
| Lilly USA, LLCTrulicity | $17 | $93,41888 claims |
| Novo NordiskOzempic, Rybelsus | $34 | $81,84150 claims |
| Johnson & JohnsonXarelto, Invokana | $20 | $80,828147 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $172 | $36,55463 claims |
| Astellas Pharma US IncMyrbetriq | $29 | $23,48972 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in del Norte
- Clint FlanaganDacono$7.6M
- Larry OdekirkCastle Rock$6.3M
- Ripley HollisterColorado Springs$5.5M
- Timothy ColanderAurora$3.1M
- Mia ScottDenver$993K
- Matthew LewisAurora$960K
- Ethan LazarusDenver$688K
- Patrick BarryFraser$568K
- Astrid LampeyFraser$568K
- Kari UusinarkausWoodland Park$520K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.